(Q43191366)

15 November 2017

Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha (English)

1 reference

15 November 2017

0 references

0 references

1 reference

Elena Frati

2

0 references

Mauro Galeazzi

7

object named as

Mauro Galeazzi

1 reference

15 November 2017

Renato De Stefano

1

1 reference

15 November 2017

Fernando Nargi

3

1 reference

15 November 2017

Caterina Baldi

4

1 reference

15 November 2017

Luana Menza

5

1 reference

15 November 2017

Mohammed Hammoud

6

1 reference

15 November 2017

language of work or name

1 reference

16 January 2010

1 reference

15 November 2017

Clinical Rheumatology

1 reference

15 November 2017

29

1 reference

15 November 2017

5

1 reference

15 November 2017

517-524

1 reference

Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide

15 November 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10067-009-1349-Y

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

21 January 2018

1 reference

12 December 2020

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had

1 reference

12 December 2020

The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study

1 reference

12 December 2020

Safety of infliximab used in combination with leflunomide or azathioprine in daily clinical practice

1 reference

12 December 2020

Infliximab and leflunomide combination therapy in rheumatoid arthritis: an open-label study

1 reference

12 December 2020

Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial

1 reference

12 December 2020

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

1 reference

12 December 2020

Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis.

1 reference

12 December 2020

Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).

1 reference

12 December 2020

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

12 December 2020

Use of combination of leflunomide with biological agents in treatment of rheumatoid arthritis

1 reference

12 December 2020

Classic disease modifying anti-rheumatic drugs (DMARDs) in combination with infliximab. The Finnish experience.

1 reference

12 December 2020

Effectiveness and safety of infliximab combined with leflunomide in chronic polyarthritis

1 reference

12 December 2020

Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison

1 reference

12 December 2020

Treatment continuation in patients receiving biological agents or conventional DMARD therapy

1 reference

12 December 2020

Safety and efficacy of leflunomide and infliximab versus methotrexate and infliximab combination therapy in rheumatoid arthritis

1 reference

12 December 2020

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

1 reference

12 December 2020

The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis

1 reference

12 December 2020

Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide

1 reference

12 December 2020

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

12 December 2020

Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes

1 reference

12 December 2020

Preliminary evaluation in rheumatoid arthritis activity in patients treated with TNF-alpha blocker plus methotrexate versus methotrexate or leflunomide alone

1 reference

12 December 2020

Combination treatment with infliximab and leflunomide in patients with active rheumatoid arthritis: safety and efficacy in an open-label clinical trial.

1 reference

12 December 2020

The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study

1 reference

12 December 2020

Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis.

1 reference

12 December 2020

10.1007/S10067-009-1349-Y

Identifiers

DOI

1 reference

15 November 2017

1 reference